Results 21 to 30 of about 3,826 (237)

Nocardial infections: report of 22 cases Infecções por Nocardia species: relato de 22 casos [PDF]

open access: yesRevista do Instituto de Medicina Tropical de São Paulo, 2007
Twenty-two cases of nocardial infections were diagnosed in our city between 1977- 1998. All patients whose clinical specimens showed Nocardia spp. at Gram stain, which were further confirmed by culture, were selected to be included in the study.
Maria Bernadete F. Chedid   +4 more
doaj   +3 more sources

Differential activity of innate defense antimicrobial peptides against Nocardia species [PDF]

open access: yesBMC Microbiology, 2010
Background Members of the genus Nocardia are ubiquitous environmental saprophytes capable to cause human pulmonary, disseminated and cutaneous nocardiosis or bovine mastitis.
Wagner Dirk   +6 more
doaj   +5 more sources

Efficacy of DA-7218, a New Oxazolidinone Prodrug, in the Treatment of Experimental Actinomycetoma Produced by Nocardia brasiliensis [PDF]

open access: goldMolecules, 2008
Two recently synthesized oxazolidinones: (R)-3-(4-(2-(2-methyltetrazol-5-yl)-pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one (DA-7157) and itscorresponding pro-drug (R)-3-(4-(2-(2-methyltetrazol-5-yl)-pyridin-5-yl)-3-fluorophenyl)-2-oxo-5 ...
Lucio Vera-Cabrera   +8 more
doaj   +2 more sources

Decrease of virulence for BALB/c mice produced by continuous subculturing of Nocardia brasiliensis [PDF]

open access: yesBMC Infectious Diseases, 2011
Background Subculturing has been extensively used to attenuate human pathogens. In this work we studied the effect of continuous subculturing of Nocardia brasiliensis HUJEG-1 on virulence in a murine model.
Ocampo-Candiani Jorge   +6 more
doaj   +4 more sources

Inmunoglobulinas en pacientes con actinomicetoma por Nocardia brasiliensis Immunoglobulins in patients with Nocardia brasiliensis actinomycetoma

open access: yesRevista Argentina de Microbiología, 2004
Considerando que algunos autores han reportado un aumento en la cantidad de algunas inmunoglobulinas en los pacientes con actinomicetoma, en este trabajo nos propusimos determinar diferencias en la producción de IgG1, IgG2, IgG3, IgG4 e IgM en 25 ...
L. J. Méndez-Tovar   +8 more
doaj   +1 more source

Micetoma por Nocardia brasiliensis: reporte de caso

open access: yesRevista Peruana de Medicina Experimental y Salud Pública, 2003
Se presenta el caso de un paciente peruano, agricultor, con una infección cutánea de origen traumático causada por Nocardia brasiliensis, que evolucionó hacia la amputación del miembro inferior afectado.
Miriam Guevara R   +4 more
doaj   +2 more sources

<i>Nocardia</i> Infection Presented as Intramuscular Abscess in a Kidney Transplant Recipient: Case Report and Literature Review. [PDF]

open access: yesCase Rep Nephrol
Background Nocardia is a gram‐positive bacterium capable of causing both local and systemic infections, typically in immunocompromised patients. The most common clinical presentation is pulmonary infection. Muscle abscess due to Nocardia infection without disseminated nocardiosis is rare.
Spangenberg G   +4 more
europepmc   +2 more sources

Global Burden of Human Mycetoma: A Systematic Review and Meta-analysis [PDF]

open access: yes, 2013
Mycetoma is a chronic infectious disease of the subcutaneous tissue with a high morbidity. This disease has been reported from countries between 30°N and 15°S since 1840 but the exact burden of disease is not known.
Sande, W.W.J. (Wendy) van de
core   +21 more sources

The impact of AlphaFold Protein Structure Database on the fields of life sciences

open access: yesPROTEOMICS, Volume 23, Issue 17, September 2023., 2023
Abstract Arguably, 2020 was the year of high‐accuracy protein structure predictions, with AlphaFold 2.0 achieving previously unseen accuracy in the Critical Assessment of Protein Structure Prediction (CASP). In 2021, DeepMind and EMBL‐EBI developed the AlphaFold Protein Structure Database to make an unprecedented number of reliable protein structure ...
Mihaly Varadi, Sameer Velankar
wiley   +1 more source

Home - About - Disclaimer - Privacy